Summary
Updated Aug 31, 2026
Sireesh Appajosyula is Chief Operating Officer, Director of Hepion Pharmaceuticals, Inc. (HEPA). 7 SEC Form 4 filings on record going back to 2024, most recently on 21 August 2026. Most recent open-market trade: bought $100K of HEPA on 13 August 2026. Lifetime open-market purchases: $170K.
Recent Transactions
4Every recent SEC Form 4 transaction Sireesh Appajosyula has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| Total purchases tracked | 3 |
| Purchases with forward-return data | 1 |
| 30-day win rate | 100% |
| 90-day win rate | 100% |
| Avg 5-day return | +55.25% |
| Avg 30-day return | +128.00% |
| Avg 90-day return | +12.50% |
| Best 30-day return | +128.00% |
Trading Pattern
InsiderAlpha's records for Sireesh Appajosyula go back to 2024: 7 primary Form 4 filings, an average of 2.3 per year. The typical open-market purchase is $34K (5 buys totaling $170K). The largest single buy on record is $100K of HEPA in 2026. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Sireesh Appajosyula files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Vincent S. Lopriore - $750K of HEPA open-market activity in the last 12 months
- Michael J. Purcell - $150K of HEPA open-market activity in the last 12 months
- Gary S. Stetz - $150K of HEPA open-market activity in the last 12 months
- Gary S. Stetz II - $25K of HEPA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Sireesh Appajosyula?
Sireesh Appajosyula is a corporate insider, tracked as Chief Operating Officer, Director of Hepion Pharmaceuticals, Inc. (HEPA). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Sireesh Appajosyula submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Sireesh Appajosyula been buying or selling stock?
Recorded transactions: 5 open-market purchases ($170K) and 0 open-market sales across all tracked filings.
How accurate is Sireesh Appajosyula's historical track record?
Across 3 tracked purchases, Sireesh Appajosyula averaged +128.0% avg 30-day return with a 100% 30-day win rate.
Where can I see all of Sireesh Appajosyula's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Sireesh Appajosyula and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial